(688198)"Beijing Balance Medical Technology Co., Ltd."Report for Q3 2026
Filed with SSE · Stock code 688198 · · 14 pages · Chinese
Summary by 6ix AI
The report highlights a significant increase in revenue and net profit compared to the same period last year, indicating a recovery in business performance. The company also notes improvements in cash flow and a stable market share for its products following recent pricing adjustments in the industry. Despite these gains, the report mentions a decline in net profit for the year-to-date period due to increased operational costs and investments in research and development.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
Beijing Balance Medical Technology Co. Ltd. on 6ix
Earlier from Beijing Balance Medical Technology
- (688198)"Beijing Balance Medical Technology Co., Ltd."Announcement on Voluntary Disclosure Regarding the Entry of the Minimally Invasive Pre-positionable Sutureless Aortic Valve System into the Special Review Procedure for Innovative Medical Devices
- (688198)"Beijing Balance Medical Technology Co., Ltd."Announcement on Voluntary Disclosure of Entry of ePTFE Pulmonary Artery Valved Conduit into the Special Review Procedure for Innovative Medical Devices
- (688198)"Beijing Balance Medical Technology Co., Ltd."Announcement on Vesting Results for the 4th Vesting Period of the Reserved Grant under the 2020 Restricted Share Incentive Plan and Listing of Shares
- (688198)"Beijing Balance Medical Technology Co., Ltd."Announcement on Voluntary Disclosure of the Approval for Registration of the Innovative Product Transcatheter Pulmonary Valve System
- Announcement on Implementation Results of Share Repurchase
Later from Beijing Balance Medical Technology
All Beijing Balance Medical Technology news releasesFollow Beijing Balance Medical Technology into a list and get an email when it puts out news.
Follow Beijing Balance Medical Technology